vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.

MARINE PRODUCTS CORP is the larger business by last-quarter revenue ($64.6M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). MARINE PRODUCTS CORP runs the higher net margin — 3.7% vs -19.9%, a 23.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 35.0%). MARINE PRODUCTS CORP produced more free cash flow last quarter ($4.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -3.5%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.

ABCL vs MPX — Head-to-Head

Bigger by revenue
MPX
MPX
1.4× larger
MPX
$64.6M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+753.3% gap
ABCL
788.4%
35.0%
MPX
Higher net margin
MPX
MPX
23.6% more per $
MPX
3.7%
-19.9%
ABCL
More free cash flow
MPX
MPX
$48.7M more FCF
MPX
$4.1M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-3.5%
MPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
MPX
MPX
Revenue
$44.9M
$64.6M
Net Profit
$-8.9M
$2.4M
Gross Margin
19.6%
Operating Margin
-63.7%
5.8%
Net Margin
-19.9%
3.7%
Revenue YoY
788.4%
35.0%
Net Profit YoY
73.9%
-44.6%
EPS (diluted)
$-0.03
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
MPX
MPX
Q4 25
$44.9M
$64.6M
Q3 25
$9.0M
$53.1M
Q2 25
$17.1M
$67.7M
Q1 25
$4.2M
$59.0M
Q4 24
$5.0M
$47.8M
Q3 24
$6.5M
$49.9M
Q2 24
$7.3M
$69.5M
Q1 24
$10.0M
$69.3M
Net Profit
ABCL
ABCL
MPX
MPX
Q4 25
$-8.9M
$2.4M
Q3 25
$-57.1M
$2.6M
Q2 25
$-34.7M
$4.2M
Q1 25
$-45.6M
$2.2M
Q4 24
$4.3M
Q3 24
$-51.1M
$3.4M
Q2 24
$-36.9M
$5.6M
Q1 24
$-40.6M
$4.6M
Gross Margin
ABCL
ABCL
MPX
MPX
Q4 25
19.6%
Q3 25
19.2%
Q2 25
19.1%
Q1 25
18.6%
Q4 24
19.2%
Q3 24
18.4%
Q2 24
18.9%
Q1 24
20.2%
Operating Margin
ABCL
ABCL
MPX
MPX
Q4 25
-63.7%
5.8%
Q3 25
-851.8%
5.4%
Q2 25
-290.2%
7.1%
Q1 25
-1479.6%
4.4%
Q4 24
7.7%
Q3 24
-1439.4%
7.2%
Q2 24
-1276.2%
8.3%
Q1 24
-551.5%
7.6%
Net Margin
ABCL
ABCL
MPX
MPX
Q4 25
-19.9%
3.7%
Q3 25
-637.8%
5.0%
Q2 25
-203.3%
6.1%
Q1 25
-1077.2%
3.7%
Q4 24
8.9%
Q3 24
-785.4%
6.8%
Q2 24
-504.3%
8.0%
Q1 24
-408.0%
6.6%
EPS (diluted)
ABCL
ABCL
MPX
MPX
Q4 25
$-0.03
$0.07
Q3 25
$-0.19
$0.07
Q2 25
$-0.12
$0.12
Q1 25
$-0.15
$0.06
Q4 24
$0.13
Q3 24
$-0.17
$0.10
Q2 24
$-0.13
$0.14
Q1 24
$-0.14
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
MPX
MPX
Cash + ST InvestmentsLiquidity on hand
$128.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$125.0M
Total Assets
$1.4B
$147.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
MPX
MPX
Q4 25
$128.5M
Q3 25
$83.2M
Q2 25
$92.4M
Q1 25
$159.3M
Q4 24
$156.3M
Q3 24
$126.6M
Q2 24
$148.3M
Q1 24
$123.6M
Stockholders' Equity
ABCL
ABCL
MPX
MPX
Q4 25
$966.9M
$125.0M
Q3 25
$964.0M
$126.3M
Q2 25
$1.0B
$127.2M
Q1 25
$1.0B
$126.4M
Q4 24
$1.1B
$129.0M
Q3 24
$1.1B
$128.8M
Q2 24
$1.1B
$129.3M
Q1 24
$1.1B
$151.4M
Total Assets
ABCL
ABCL
MPX
MPX
Q4 25
$1.4B
$147.2M
Q3 25
$1.4B
$179.5M
Q2 25
$1.4B
$173.2M
Q1 25
$1.3B
$182.9M
Q4 24
$1.4B
$171.2M
Q3 24
$1.4B
$176.3M
Q2 24
$1.4B
$175.7M
Q1 24
$1.5B
$204.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
MPX
MPX
Operating Cash FlowLast quarter
$-34.7M
$4.7M
Free Cash FlowOCF − Capex
$-44.6M
$4.1M
FCF MarginFCF / Revenue
-99.4%
6.4%
Capex IntensityCapex / Revenue
21.9%
0.9%
Cash ConversionOCF / Net Profit
2.00×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
MPX
MPX
Q4 25
$-34.7M
$4.7M
Q3 25
$-52.6M
$2.6M
Q2 25
$-32.4M
$-1.6M
Q1 25
$-11.6M
$10.8M
Q4 24
$-108.6M
$4.6M
Q3 24
$-28.9M
$5.1M
Q2 24
$-30.0M
$3.8M
Q1 24
$-41.7M
$15.9M
Free Cash Flow
ABCL
ABCL
MPX
MPX
Q4 25
$-44.6M
$4.1M
Q3 25
$-61.5M
$2.1M
Q2 25
$-45.8M
$-2.0M
Q1 25
$-22.2M
$10.7M
Q4 24
$-187.0M
$3.6M
Q3 24
$-47.4M
$3.2M
Q2 24
$-50.1M
$3.0M
Q1 24
$-65.8M
$15.0M
FCF Margin
ABCL
ABCL
MPX
MPX
Q4 25
-99.4%
6.4%
Q3 25
-687.0%
4.0%
Q2 25
-267.9%
-3.0%
Q1 25
-524.0%
18.1%
Q4 24
-3702.8%
7.6%
Q3 24
-728.4%
6.5%
Q2 24
-683.8%
4.4%
Q1 24
-661.5%
21.7%
Capex Intensity
ABCL
ABCL
MPX
MPX
Q4 25
21.9%
0.9%
Q3 25
99.7%
0.8%
Q2 25
78.2%
0.6%
Q1 25
251.1%
0.2%
Q4 24
1552.7%
2.1%
Q3 24
284.6%
3.8%
Q2 24
274.6%
1.1%
Q1 24
242.5%
1.3%
Cash Conversion
ABCL
ABCL
MPX
MPX
Q4 25
2.00×
Q3 25
0.97×
Q2 25
-0.39×
Q1 25
4.88×
Q4 24
1.09×
Q3 24
1.51×
Q2 24
0.68×
Q1 24
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

MPX
MPX

Boats And Accessories$63.4M98%
Parts$1.1M2%

Related Comparisons